NYSE:RES
NYSE:RESEnergy Services

Will Higher Sales but Lower Profits Reshape RPC's (RES) Investment Narrative?

RPC, Inc. recently reported third quarter 2025 earnings, revealing US$447.1 million in sales, a year-over-year increase, but a decrease in net income to US$12.96 million compared to US$18.8 million a year earlier. While sales growth was strong, the decline in profitability stands out, as it signals higher operating costs or margin pressures despite revenue gains. We'll examine how RPC's latest earnings, marked by higher sales but lower profits, reshape the company's investment...
NYSE:WTRG
NYSE:WTRGWater Utilities

A Fresh Look at Essential Utilities (WTRG) Valuation After Upbeat Earnings and Raised Guidance

Essential Utilities (WTRG) just delivered a solid update, reporting higher sales and net income for both its third quarter and nine-month results compared to last year. Management also raised its full-year earnings guidance due to recent non-recurring benefits, which caught investors’ attention. See our latest analysis for Essential Utilities. Essential Utilities’ upbeat earnings and guidance have helped the stock regain momentum, with a share price return of 9.5% so far in 2025. While the...
NYSE:INR
NYSE:INROil and Gas

A Fresh Look at Infinity Natural Resources (INR) Valuation Following Q3 Earnings, Buyback, and Production Guidance Update

Infinity Natural Resources (NYSE:INR) just rolled out a series of key updates, including its third-quarter 2025 earnings results, a tightened full-year production outlook, and a newly authorized $75 million share buyback program. See our latest analysis for Infinity Natural Resources. It’s been a dramatic stretch for Infinity Natural Resources, with the share price soaring 15.25% in a single day and 19.03% over the past week, following the company’s upbeat Q3 earnings, tightened production...
NasdaqCM:APPS
NasdaqCM:APPSSoftware

How Digital Turbine's (APPS) Raised Revenue Outlook and Board Changes May Shape Its Investment Story

Digital Turbine recently reported second quarter financial results, showing year-over-year revenue growth to US$140.38 million and a reduction in net loss to US$21.4 million, alongside raised revenue guidance for fiscal year 2026 to a range of US$540 million to US$550 million. This update also included the resignation of board member Mollie Spilman, who departed to pursue a senior executive role elsewhere, adding to the evolving leadership outlook at the company. To assess the implications...
NYSE:EQH
NYSE:EQHDiversified Financial

Can Equitable Holdings’ Recent 8% Drop Signal a Bargain for Investors in 2025?

Ever wondered if Equitable Holdings could be an overlooked bargain or if the recent buzz is justified? You are not alone in wanting to dig into whether the current price makes sense. While the stock is up a hefty 109% over the past five years and 58% over three years, recent months have been bumpier with an 8.1% drop this week and a 7.2% decline over the last 30 days. Investor sentiment has been shifting as the market responds to sector-wide uncertainty and regulatory updates affecting...
NYSE:NRP
NYSE:NRPOil and Gas

How Investors Are Reacting To Natural Resource Partners (NRP) Lower Q3 Revenue and Joint Venture Distributions

Natural Resource Partners L.P. announced past third quarter 2025 results, reporting a year-over-year decrease in both revenue and net income due to weaker coal and soda ash market conditions. While the company highlighted ongoing deleveraging efforts and positive free cash flow, it also confirmed no distributions from its soda ash joint venture in this period. We’ll explore how the absence of joint venture distributions amid lower coal royalty revenues shapes the company's investment...
NasdaqGM:VWAV
NasdaqGM:VWAVAerospace & Defense

Will VisionWave (VWAV) Prove Its Autonomous Edge as Varan UGV Heads for European Field Trials?

VisionWave Holdings announced upcoming European field testing of its Varan UGV, a next-generation autonomous and modular ground vehicle platform designed to transform modern defense with coordinated swarm capabilities, modular payloads, and advanced navigation features. With its ability to rapidly adapt to diverse battlefield roles and operate as a swarm, the Varan platform showcases VisionWave’s ambition to lead the shift toward autonomous intelligence in ground combat operations. We’ll...
NasdaqCM:HNRG
NasdaqCM:HNRGRenewable Energy

Hallador Energy (HNRG) Is Up 17.0% After Swinging to Strong Profitability in Q3 - Has The Bull Case Changed?

Hallador Energy Company recently reported its third quarter and nine-month 2025 results, highlighting a large increase in sales and a shift from a net loss to significant net income year-over-year. This earnings report reveals a sharp improvement in profitability, as basic earnings per share from continuing operations jumped to US$0.98 for the nine months compared to a loss of US$0.27 a year earlier. With robust year-over-year net income growth, we’ll explore how Hallador Energy’s improved...
NasdaqGS:MTSR
NasdaqGS:MTSRBiotechs

Metsera (MTSR): Assessing Valuation After This Year’s 167% Stock Surge

Metsera (MTSR) has seen its stock shift modestly over the past week, with a month-long climb of 34% catching some investors’ attention. This move comes as market interest grows around the company’s future prospects. See our latest analysis for Metsera. Metsera’s 1-month share price return of nearly 34% stands out, especially as the stock has surged by over 167% so far this year. While shorter-term momentum cooled slightly this past week, overall sentiment remains optimistic. Recent gains...
NasdaqGM:PUBM
NasdaqGM:PUBMMedia

PubMatic (PUBM) Valuation in Focus After Q3 Sales Decline and Wider Net Loss

PubMatic (PUBM) just released its third quarter earnings report, highlighting a drop in sales and a larger net loss compared to last year. In addition to these results, the company shared new revenue guidance for the upcoming quarter. See our latest analysis for PubMatic. After a tough year marked by a 33.2% total shareholder loss, PubMatic’s share price staged a dramatic turnaround, soaring 43% in just one day and rallying over 37% in the past month. This sudden momentum suggests a sharp...
NYSE:CBU
NYSE:CBUBanks

Community Financial System (CBU): Assessing Valuation After Recent Modest Share Price Gains

Community Financial System (CBU) shares have edged up about 2% over the last week, continuing a gradual rise that has seen the stock gain 3% over the past month. Investors appear to be weighing recent financial results and ongoing sector trends. See our latest analysis for Community Financial System. Even with the recent uptick, Community Financial System’s year-long total shareholder return stands at -15.0%, reflecting continued caution in the regional banking sector. Momentum has picked up...
NasdaqGS:BATR.K
NasdaqGS:BATR.KEntertainment

The Bull Case For Atlanta Braves Holdings (BATR.K) Could Change Following Return to Profitability and Revenue Growth

Atlanta Braves Holdings, Inc. recently announced its third-quarter 2025 financial results, reporting revenue of US$311.54 million and net income of US$29.98 million, both higher than the same period last year. The company also achieved a significant turnaround over the nine-month period, moving from a net loss to a net profit and posting strong year-over-year growth in earnings per share. We'll examine how these robust earnings improvements shape Atlanta Braves Holdings' investment...
NasdaqCM:ABEO
NasdaqCM:ABEOBiotechs

Abeona Therapeutics (ABEO): Assessing Value After J-Code Milestone for ZEVASKYN Approval

Abeona Therapeutics (ABEO) just announced that the Centers for Medicare and Medicaid Services has established a permanent J-code for ZEVASKYN, its gene therapy for RDEB. The code takes effect in January 2026, making billing and access for providers more efficient. See our latest analysis for Abeona Therapeutics. Even with this major regulatory milestone for ZEVASKYN, Abeona Therapeutics’ share price return has been under pressure, with a 30-day retreat of 22.2% and a year-to-date slide of...
NasdaqGM:AVDL
NasdaqGM:AVDLPharmaceuticals

Did Avadel Pharmaceuticals’ (AVDL) Surprise Profitability Turn Just Shift Its Investment Narrative?

Avadel Pharmaceuticals plc recently reported earnings for the third quarter and nine months ended September 30, 2025, posting a net income of US$0.02 million and US$4.77 million for these periods respectively, compared to net losses a year ago. This marks a turnaround for the company, with basic and diluted earnings per share from continuing operations improving from a US$0.46 loss to a US$0.05 profit year-over-year. We'll explore how Avadel's swing to profitability this quarter could impact...
NasdaqGS:CHYM
NasdaqGS:CHYMDiversified Financial

Why Chime Financial (CHYM) Is Up 19.1% After Raising 2025 Guidance and Showcasing Strong Growth

Chime Financial recently raised its earnings guidance for the fourth quarter and full year 2025, projecting full-year revenue between US$2.16 billion and US$2.17 billion alongside stronger profitability forecasts. The company highlighted robust execution, marked by a significant rise in active members, expansion of new products like the Chime Card, and the successful rollout of its proprietary processing platform. With a 19.1% seven-day share price gain, we'll examine how Chime's raised...
NasdaqGS:HUMA
NasdaqGS:HUMABiotechs

Could Humacyte's (HUMA) High-Risk Patient Focus Redefine Its Competitive Edge in Biotech?

Humacyte recently announced positive two-year results from its Phase 3 V007 clinical trial, showing that its acellular tissue engineered vessel (ATEV) provided superior duration of use in high-risk hemodialysis patients compared to the standard autogenous fistula, with findings presented at the American Society of Nephrology’s Kidney Week 2025. A notable insight from the data is that the ATEV offered a substantially longer average access duration for female, obese, and diabetic patients,...
NasdaqCM:DCTH
NasdaqCM:DCTHMedical Equipment

Delcath Systems (DCTH): Exploring Valuation After Surprise Net Income Turnaround

Delcath Systems (DCTH) caught attention after sharing its third quarter and nine-month results, revealing a shift from last year’s net loss to net income for the current period. This turnaround is of interest to many investors. See our latest analysis for Delcath Systems. Delcath Systems’ turnaround has certainly made waves, but the optimism has not yet translated into momentum for the share price. While the company’s recent swing to net income signals progress, the 1-year total shareholder...